Prevalencia de Anticuerpos contra el Sars Cov 2, en gestantes atendidas en el Hospital Iquitos Cesar Garayar Garcia Abril- Junio 2021
Date
2023-02-22
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Científica del Perú
Abstract
El objetivo del presente estudio fue de determinar la prevalencia de
anticuerpos contra el Sars Cov 2, en gestantes atendidas en el Hospital
Iquitos Cesar Garayar García Abril- Junio 2021.
El diseño de investigación utilizado fue descriptivo, prospectivo y
transversal. La población estuvo conformada en total por 667 gestantes
que se hicieron prueba de anticuerpos contra el Sars Cov 2. La técnica
que se empleó en la recolección de datos fue de recolección de fuente
primaria y el instrumento de recolección de datos fueron las fichas de
resultados.
En nuestro estudio, se encontró una prevalencia de 8,0% , 33 y 38 % con
resultados positivos a los anticuerpos anti-SARS-CoV-2 IgM e IgG , IgG
e IgM, respectivamente.
La prevalencia general de anticuerpos contra el Sars Cov 2, en gestantes
atendidas en el Hospital Iquitos Cesar Garayar García Abril- Junio 2021
fue del 79 %.
The objective of the present study was to determine the prevalence of antibodies against Sars Cov 2, in pregnant women treated at the Iquitos Cesar Garayar García Hospital April-June 2021. The research design used was descriptive, prospective and crosssectional. The population was made up of a total of 667 pregnant women who were tested for antibodies against Sars Cov 2. The technique used in data collection was the primary source collection and the data collection instrument was the results sheets. In our study, a prevalence of 8.0%, 33 and 38% with positive results for anti-SARS-CoV-2 IgM and IgG, IgG and IgM antibodies, respectively, was found. The general prevalence of antibodies against Sars Cov 2, in pregnant women treated at the Iquitos Cesar Garayar García Hospital April-June 2021 was 79%.
The objective of the present study was to determine the prevalence of antibodies against Sars Cov 2, in pregnant women treated at the Iquitos Cesar Garayar García Hospital April-June 2021. The research design used was descriptive, prospective and crosssectional. The population was made up of a total of 667 pregnant women who were tested for antibodies against Sars Cov 2. The technique used in data collection was the primary source collection and the data collection instrument was the results sheets. In our study, a prevalence of 8.0%, 33 and 38% with positive results for anti-SARS-CoV-2 IgM and IgG, IgG and IgM antibodies, respectively, was found. The general prevalence of antibodies against Sars Cov 2, in pregnant women treated at the Iquitos Cesar Garayar García Hospital April-June 2021 was 79%.
Description
Keywords
Sars Cov 2, Anticuerpos, Gestante, Prevalencia, Sars Cov 2, Antibodies, Pregnant woman, Prevalence
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as info:eu-repo/semantics/openAccess